Volker Scherhammer

Apceth Biopharma (Germany) — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

1h-index75citations4works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(1), Cancer Cells and Metastasis(1), Virus-based gene therapy research(1), Cancer, Hypoxia, and Metabolism(1), RNA Interference and Gene Delivery(1)

Publications4 total

TREAT-ME 1: Treatment of advanced gastrointestinal cancer in a clinical phase I/II trial with genetically modified mesenchymal stem cells: Clinical results of a phase I study.
Journal of Clinical Oncology·2015
615: Cell-based biopharmaceuticals in a Phase I/II trial (TREAT-ME 1) for targeted drug- and gene delivery as an innovative treatment modality in advanced cancer
European Journal of Cancer·2014
Biochemische und molekularbiologische Charakterisierung von CybL und Saip, zweier dominant apoptoseinduzierender Gene
Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)·2004Open Access
The Tumor Suppressor cybL, a Component of the Respiratory Chain, Mediates Apoptosis Induction
Molecular Biology of the Cell·2003· 75 citedOpen Access

Frequent Co-authors

Hanno Nieß(2), Marlies Michl(2), Volker Heinemann(2), Timur Albayrak(1), Nicole Schoenfeld(1), Erik Braziulis(1), Thomas Mund(1), Manuel Bauer(1), Immo E. Scheffler(1), Stefan Grimm(1), Jobst C. von Einem(1), Peter J. Nelson(1), Christine Guenther(1), Christoph Salat(1), Oliver J. Stoetzer(1), Martin K. Angele(1), Christiane J. Bruns(1), Ryan S. Huss(1), Jobst von Einem(1), Felix G. Hermann(1)